

Generic Name: Colloidal silver
Argyrol®, electro colloidal silver, electro-colloidal silver, ionic silver, ProAg catheter, silver protein, silver protein solution.
Colloidal silver is a suspension of submicroscopic metallic silver particles in a colloidal base. Long-term use of silver preparations can lead to argyria, a permanent condition in which silver salts deposit in the skin, eyes, and internal organs. The skin can often appear ashen-gray due to the deposition of the silver salts. Argyria has been mistaken for cyanotic heart disease.
Today, colloidal silver is not generally recognized as safe or effective. However, some researchers believe that it has antibacterial properties, which may warrant further studies. Despite the lack of scientific evidence, colloidal silver is most commonly used as a natural antibiotic or healing agent. It is either applied to the skin or ingested as a drink to promote healing or to combat disease.
The U.S. Food and Drug Administration (FDA) has taken action against several colloidal drug companies, including Web site advertisers, for making unsubstantiated claims for their product. Colloidal silver products are usually marketed as dietary supplements. Therefore, the manufacturers do not need to go through the same rigorous approval processes as drug companies.
There is no proven safe or effective dose for colloidal silver in adults.
There is no proven safe or effective dose for colloidal silver in children.
Avoid in individuals with a known allergy or hypersensitivity to silver. Allergy to silver protein has been reported.
Colloidal silver is likely unsafe when taken by mouth or applied to the skin. The U.S. Food and Drug Administration (FDA) issued a final rule in August 1999 establishing that all over-the-counter (OTC) drug products containing colloidal silver ingredients or silver salts for internal or external use are not Generally Recognized as Safe (GRAS) and effective and are misbranded. This rule was issued because colloidal silver has been marketed for many serious disease conditions. Colloidal silver may also cause kidney damage, stomach distress, headaches, fatigue, and skin irritation.
Colloidal silver is not recommended in pregnant or breastfeeding women due to a lack of available scientific evidence.
Insufficient available evidence.
Insufficient available evidence.
This information is based on a systematic review of scientific literature, and was peer-reviewed and edited by contributors to the Natural Standard Research Collaboration (www.naturalstandard.com): Dawn Costa, BA, BS (Natural Standard Research Collaboration); Chi Dam, PharmD (Northeastern University); Nicole Giese, MS (Natural Standard Research Collaboration); Mary Giles, PharmD (University of Rhode Island); Catherine DeFranco Kirkwood, MPH, CCCJS-MAC (MD Anderson Cancer Center); Tamara Milkin, PharmD (Northeastern University); Kristen Rafuse, BS (Northeastern University); Kris Swinney, PharmD (Massachusetts College of Pharmacy); Brian Szczechowski, PharmD (Massachusetts College of Pharmacy); Shaina Tanguay-Colucci, BS (Natural Standard Research Collaboration); Chris Tonelli, MA (Emmanuel College); Catherine Ulbricht, PharmD (Massachusetts General Hospital); Wendy Weissner, BA (Natural Standard Research Collaboration); Lisa Wendt, PharmD (University of Albany); Jen Woods, BS (Northeastern University).
Brentano L, Margraf H, Monafo WW, et al. Antibacterial efficacy of a colloidal silver complex. Surg Forum 1966;17:76-78.
Chang AL, Khosravi V, Egbert B. A case of argyria after colloidal silver ingestion. J Cutan Pathol 2006 Dec;33(12):809-11.
Fujimoto T, Sainoo T, Kamisaka M. [Silver-protein allergy]. Jibiinkoka 1970;42(1):33-36.
Gulbranson SH, Hud JA, Hansen RC. Argyria following the use of dietary supplements containing colloidal silver protein. Cutis 2000;66(5):373-374.
Isenberg S, Apt L, Yoshimuri R. Chemical preparation of the eye in ophthalmic surgery. II. Effectiveness of mild silver protein solution. Arch Ophthalmol 1983;101(5):764-765.
McKenna JK, Hull CM, Zone JJ. Argyria associated with colloidal silver supplementation. Int J Dermatol 2003;42(7):549.
Mirsattari SM, Hammond RR, Sharpe MD, et al. Myoclonic status epilepticus following repeated oral ingestion of colloidal silver. Neurology 2004;62(8):1408-1410.
Okan D, Woo K, Sibbald RG. So what if you are blue? Oral colloidal silver and argyria are out: safe dressings are in. Adv Skin Wound Care 2007;20(6):326-330.
Parker WA. Argyria and cyanotic heart disease. Am J Hosp Pharm 1977;34(3):287-289.
Spratt DA, Pratten J, Wilson M, et al. An in vitro evaluation of the antimicrobial efficacy of irrigants on biofilms of root canal isolates. Int Endod J 2001;34(4):300-307.
White JM, Powell AM, Brady K, et al. Severe generalized argyria secondary to ingestion of colloidal silver protein. Clin Exp Dermatol 2003;28(3):254-256.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.


